The Application of HE4 in Diagnosis of Gynecological Pelvic Malignant Tumor
OBJECTIVE To investigate the value of human epididymis gene product 4 (HE4) in differential diagnosis of gynecological pelvic tumors. METHODS The level of serum HE4 in 132 women was determined. These women were divided into three groups, i.e., 46 women with good health being classified as the...
Main Authors: | Shuyi WANG, Lixin DONG, Hongchen LI |
---|---|
Format: | Article |
Language: | English |
Published: |
China Anti-Cancer Association
2009-02-01
|
Series: | Cancer Biology & Medicine |
Subjects: | |
Online Access: | http://www.cancerbiomed.org/index.php/cocr/article/view/180 |
Similar Items
-
Stacking Machine Learning Algorithms for Biomarker-Based Preoperative Diagnosis of a Pelvic Mass
by: Reid Shaw, et al.
Published: (2022-03-01) -
HE4 (WFDC2) Promotes Tumor Growth in Endometrial Cancer Cell Lines
by: Sean Dowdy, et al.
Published: (2013-03-01) -
The Use of Human Epididymis 4 and Cancer Antigen 125 Tumor Markers in the Benign or Malignant Differential Diagnosis of Pelvic or Adnexal Masses
by: Zehra Nihal Dolgun, et al.
Published: (2017-04-01) -
Predictive Value of HE4 in Platinum-Based Chemotherapy for Ovarian Cancer: A Systematic Review
by: Yue Han, et al.
Published: (2021-07-01) -
Diagnostic Performance of Risk of Malignancy Algorithm (ROMA), Risk of Malignancy Index (RMI) and Expert Ultrasound Assessment in a Pelvic Mass Classified as Inconclusive by International Ovarian Tumour Analysis (IOTA) Simple Rules
by: Siew Fei Ngu, et al.
Published: (2022-02-01)